Innovative vaccines for animal health
Vaxxinova (vaxxinova.com) scores 76 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Manufacturing brands, Other brands, in the 47th percentile of 9957 Healthcare brands.
Vaxxinova is a company headquartered in Bergen, Norway, founded in 1987, that develops and produces specialized vaccines for poultry, cattle, and aquaculture. It operates across global agricultural markets, combining scientific research with regional adaptability to address region-specific animal diseases. The company's mission is to improve animal health and welfare worldwide, serving livestock farmers, producers, and veterinary professionals in multiple countries across Africa, the Americas, Asia, Australia and Oceania, and Europe.
| Brand Name | Vaxxinova |
|---|---|
| Domain | vaxxinova.com |
| Industry | Healthcare, Manufacturing |
| Founded | 1987 |
| Headquarters | Bergen |
| Main Competitors | Zoetis (91/100), Boehringer Ingelheim (76/100), Merck Animal Health (69/100), Ceva Santé Animale (85/100), Elanco (88/100), Hipra (84/100), Phibro Animal Health (79/100) |
Moz Domain Authority 26/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Regions Choose region: Global | Africa | Americas | Asia | Australia and Oceania | Europe Africa A…" (No meta description. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: PHP, Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Instagram, GitHub; no detected presence on X (Twitter), Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Vaxxinova?", Claude could identify the brand as of September 2026. Vaxxinova is a global animal health company specializing in vaccines and vaccination-related services for livestock and other animals, operating as part of the EW Group. It focuses on developing custom and autogenous vaccines for poultry, swine, cattle, and aquaculture to address Best known for Custom and autogenous animal vaccines for livestock and aquaculture.
When asked "Best brands similar to Vaxxinova?", Claude would recommend Vaxxinova as of September 2026. It's a recognized player in animal health vaccines, particularly for tailored veterinary vaccine solutions, so I'd mention it alongside companies like Zoetis, Boehringer Ingelheim, or Ceva Santé Animale in that context.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Vaxxinova's main competitors in Healthcare: Zoetis (91/100), Boehringer Ingelheim (76/100), Merck Animal Health (69/100), Ceva Santé Animale (85/100), Elanco (88/100).
Sources: Brand Analyzer scan
Vaxxinova has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 44, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Vaxxinova official site
Vaxxinova was founded in 1987. Vaxxinova operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Vaxxinova is headquartered in Bergen. Vaxxinova operates in the Healthcare category.
Sources: Wikidata
Vaxxinova scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Vaxxinova official site
Vaxxinova can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Vaxxinova official site
Vaxxinova offers specialized vaccines for poultry, cattle, and aquaculture species, designed to address diseases specific to different regions and agricultural markets. Its offerings support livestock producers and veterinary professionals in improving animal health and productivity.
Sources: Vaxxinova official site
Vaxxinova is a company headquartered in Bergen, Norway, founded in 1987, that specializes in developing and manufacturing vaccines for livestock and aquaculture species. It operates internationally, serving agricultural markets across Africa, the Americas, Asia, Australia and Oceania, and Europe.
Sources: Vaxxinova official site
Vaxxinova develops and produces specialized vaccines for poultry, cattle, and aquaculture animals. It focuses on combating region-specific animal diseases by combining global scientific expertise with local presence in various agricultural markets, aiming to improve livestock health, welfare, and productivity.
Sources: Vaxxinova official site
Vaxxinova's products and services are used by livestock farmers, poultry and cattle producers, aquaculture operators, and veterinary professionals operating in global agricultural markets across Africa, the Americas, Asia, Australia and Oceania, and Europe.
Sources: Vaxxinova official site
Vaxxinova scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Vaxxinova has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 26/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Vaxxinova from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Vaxxinova: Sumitomo Biorational (76/100), UT Southwestern Medical Center (76/100), Vedix (76/100), Vesta Teleradiology (76/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.